SCD and cancer: The exotic expression of genes might play vital roles in cancers [9], and Kaplan-Meier analysis revealed that SCD1 high-expressed patients have relatively less-optimistic prognostic outcome in terms of overall survival (OS), post-progression survival (PPS) and progression-free survival (PFS) (OS: P <0.0001, HR = 1.67 (1.36-2.04); PPS: P = 0.023, HR = 1.39 (1.05-1.86); PFS: P <0.0001, HR = 2.04 (1.59-2.61); Figure 1G–1I).